Prediction of Proliferative Diabetic Retinopathy With Hemoglobin Level

被引:22
作者
Conway, Baqiyyah N. [1 ]
Miller, Rachel G. [1 ]
Klein, Ronald [2 ]
Orchard, Trevor J. [1 ]
机构
[1] Univ Pittsburgh, Pittsburgh, PA USA
[2] Univ Wisconsin, Madison, WI 53706 USA
基金
美国国家卫生研究院;
关键词
RETINAL VEIN OCCLUSION; CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; BLOOD-VISCOSITY; PITTSBURGH EPIDEMIOLOGY; RISK-FACTORS; OVERT NEPHROPATHY; VISUAL-ACUITY; SEX-HORMONES; ANEMIA;
D O I
10.1001/archophthalmol.2009.274
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: To investigate the role of hemoglobin (HGB) level in predicting proliferative diabetic retinopathy (PDR). Methods: We assessed 426 individuals without PDR at baseline (213 men; 213 women) from the Pittsburgh Epidemiology of Diabetes Complications Study, an 18-year prospective cohort study of childhood-onset type 1 diabetes. Presence of PDR was determined by stereo fundus photography. Cox proportional hazards modeling with stepwise regression was used to determine the independent association of HGB level with PDR. Analyses were sex specific. Results: There were 206 events. Although the incidence of PDR did not vary by sex (48% in both men and women), in men, HGB exhibited a positive linear relationship with 18-year incidence of PDR (hazard ratio, 1.33; 95% confidence interval, 1.10-1.60; P=.003), while in women, HGB level exhibited a quadratic relationship with PDR (P<.001). After multivariable adjustment for univariately significant covariates, HGB level remained significantly predictive of PDR in both men (P=.004) and women (P=.04). Conclusion: Higher HGB level predicts the incidence of PDR in type 1 diabetes mellitus, though the association varies by sex, being linear and positive in men and quadratic in women.
引用
收藏
页码:1494 / 1499
页数:6
相关论文
共 46 条
[1]   Diabetes, kidney disease and anaemia: time to tackle a troublesome triad? [J].
Al-Khoury, S. ;
Afzali, B. ;
Shah, N. ;
Thomas, S. ;
Gusbeth-Tatomir, P. ;
Goldsmith, D. ;
Covic, A. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (02) :281-289
[2]  
[Anonymous], 1976, PREV MED, V5, P207, DOI DOI 10.1016/0091-7435(76)90039-6
[3]   Anemia with erythropoietin deficiency occurs early in diabetic nephropathy [J].
Bosman, DR ;
Winkler, AS ;
Marsden, JT ;
Macdougall, IC ;
Watkins, PJ .
DIABETES CARE, 2001, 24 (03) :495-499
[4]   Association between higher cumulative doses of recombinant erythropoietin and risk for retinopathy of prematurity [J].
Brown, Mark S. ;
Baron, Anna E. ;
France, Eric K. ;
Hamman, Richard F. .
JOURNAL OF AAPOS, 2006, 10 (02) :143-149
[5]  
CHAURASIA RK, 1993, ANN OPHTHALMOL, V25, P227
[6]   Hemoglobin and overt nephropathy complications in type 1 diabetes [J].
Conway, Baqiyyah ;
Fried, Linda ;
Orchard, Tevor .
ANNALS OF EPIDEMIOLOGY, 2008, 18 (02) :147-155
[7]  
Conway BN, 2005, DIABETES, V54, pA551
[8]   Anemia and diabetes in the absence of nephropathy [J].
Craig, KJ ;
Williams, JD ;
Riley, SG ;
Smith, H ;
Owens, DR ;
Worthing, D ;
Cavill, I ;
Phillips, AO .
DIABETES CARE, 2005, 28 (05) :1118-1123
[9]   Risk factors for renal replacement therapy in the Early Treatment Diabetic Retinopathy Study (ETDRS), Early Treatment Diabetic Retinopathy Study Report No. 26 [J].
Cusick, M ;
Chew, EY ;
Hoogwerf, B ;
Agrón, E ;
Wu, L ;
Lindley, A ;
Ferris, FL .
KIDNEY INTERNATIONAL, 2004, 66 (03) :1173-1179
[10]  
Davis MD, 1998, INVEST OPHTH VIS SCI, V39, P233